Nanogen and Prodesse to Collaborate on Array Tests of Infectious Respiratory Diseases | GenomeWeb

Nanogen and Prodesse announced last week a collaboration to develop microarray-based tests for infectious disease agents such as influenza, West Nile virus, and SARS.

Prodesse, an early-stage, Milwaukee, Wis.-based firm, will provide its multiplex amplification technology for use on Nanogen’s NanoChip electronic microarray platform. The two firms will create gene-based testing products for marketing to healthcare providers and clinical reference labs.

Financial details of the deal were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.